e-learning
resources
Paris 2018
Sunday, 16.09.2018
Challenges in treating tuberculosis and nontuberculous mycobacteria
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk score of drug-induced liver injury among new tuberculosis patients
D. Ivanova (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation)
Source:
International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Session:
Challenges in treating tuberculosis and nontuberculous mycobacteria
Session type:
Poster Discussion
Number:
523
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Ivanova (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation). Risk score of drug-induced liver injury among new tuberculosis patients. 523
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Frequency, severity and risk factors of drug-induced liver injury during treatment of new tuberculosis patients
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012
Management of tuberculosis in patients with chronic liver dysfunction
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007
Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays
Source: Eur Respir J 2007; 30: Suppl. 51, 752s
Year: 2007
Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019
Risk factors for tuberculosis in patients with chronic alcoholism
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
Risk factors predicting mortality in patients with lung abscess
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012
Effectiveness of treatment and correction of side effects in pulmonary MDR/XDR TB patients with concomitant liver injury
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017
Ventilator-associated lung injury: a search for better therapeutic targets
Source: Eur Respir J 2007; 30: 1216-1226
Year: 2007
Clinical assessment for identifying causes of acute respiratory failure in cancer patients
Source: Eur Respir J 2013; 42: 435-443
Year: 2013
Pulmonary disease as a risk factor for transfusion-related acute lung injury
Source: ERJ Open Res, 7 (3) 00039-2021; 10.1183/23120541.00039-2021
Year: 2021
Risk factors for fatal tuberculosis among immunocompetent patients.
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Treatment approach to tuberculosis in patients with antituberculotic-induced liver disorders
Source: Eur Respir J 2005; 26: Suppl. 49, 650s
Year: 2005
Study of lung functions in patients of chronic liver disease.
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017
Risk factors of hepatotoxicity during tuberculosis treatment and management
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008
A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Risk factors for pulmonary
Mycobacterium avium-intracellulare
complex disease deterioration in immunocompetent patients
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Risk factors associated with death in pulmonary tuberculosis
Source: Annual Congress 2009 - Socio-economic impact of tuberculosis
Year: 2009
Screening for cystic fibrosis among high risk group patients with chronic lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002
Risk assessment in severe pulmonary hypertension due to interstitial lung disease
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients
Source: Eur Respir J 2011; 38: 643-648
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept